Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 5/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | AOC2 | O75106 | 5/20 | 0.40 |
| ▸ | MAOA | P21397 | 5/20 | 0.40 |
| ▸ | MAOB | P27338 | 5/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28272582 | 0.86 | TP53 (0.44) | HTR1ASIGMAR1HRH3ADRA2AADRA2B | |
| SCHEMBL10366708 | 0.86 | HRH3 (0.43) | HTR1ASIGMAR1HRH3AOC2MAOA | |
| SCHEMBL7086692 | 0.86 | ALDH1A1 (0.46) | HTR1ASIGMAR1HRH3AOC2MAOA | |
| SCHEMBL14435037 | 0.82 | CYP3A4 (0.49) | HTR1ASIGMAR1HRH3ADRA2AADRA2B | |
| SCHEMBL9153669 | 0.82 | HTR1A (0.66) | HTR1ASIGMAR1ADRA2AADRA2BADRA2C | |
| SCHEMBL9153673 | 0.82 | HTR1A (0.66) | HTR1ASIGMAR1ADRA2AADRA2BADRA2C | |
| SCHEMBL10368729 | 0.80 | HRH3 (0.41) | HTR1ASIGMAR1HRH3ADRA2AADRA2B | |
| SCHEMBL10750642 | 0.80 | SMN1; SMN2 (0.46) | SIGMAR1HRH3 | |
| SCHEMBL8035957 | 0.78 | DRD2 (0.53) | — | |
| SCHEMBL10736602 | 0.77 | HRH3 (0.49) | HTR1ASIGMAR1HRH3ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2766120-A1 | METHOD FOR CATALYTIC HETEROAROMATIC HYDROGENATION | Westfälische Wilhelms-Universität Münster (DE) | 2014-08-20 | — | — | EP | disclosed |
| WO-2013053796-A1 | METHOD FOR CATALYTIC HETEROAROMATIC HYDROGENATION | Westfälische Wilhelms Universität Münster (DE) | 2013-04-18 | — | — | WO | disclosed |
| WO-2013053796-A1 | METHOD FOR CATALYTIC HETEROAROMATIC HYDROGENATION | Westfälische Wilhelms Universität Münster (DE) | 2013-04-18 | — | — | WO | disclosed |
| EP-0199235-B1 | PHENYLALKYL-2,3-DIHYDROBENZOFURANS AND ANALOGS USEFUL AS ANTI-INFLAMMATORY AGENTS | MERCK & CO. INC. (US) | 1990-08-08 | — | — | EP | disclosed |
| CN-1007248-B | PROCESS FOR MANUFACTURING OF FLOOD SUGAR REDUCING MEDICINE-THIAZOLIDINEDIONS | PFIZER (US) | 1990-03-21 | — | — | CN | disclosed |
| EP-0207605-B1 | HYPOGLYCEMIC THIAZOLIDINEDIONES | PFIZER INC. (US) | 1990-02-07 | — | — | EP | disclosed |
| US-4775679-A | Certain heterocyclic-ethyl-2,3-dihydrobenzofurans useful as anti-inflammatory agents | MERCK & CO., INC. (US) | 1988-10-04 | — | — | US | disclosed |
| US-4713393-A | TOPICAL TREATMENT OF SKIN DISORDERS | MERCK & CO., INC. (US) | 1987-12-15 | — | — | US | disclosed |
| US-4703052-A | Hypoglycemic thiazolidinediones | PFIZER INC. (US) | 1987-10-27 | — | — | US | disclosed |
| CN-86104075-A | Preparation method of hypoglycemic agent-thiazolidinedione | — | 1987-03-11 | — | — | CN | disclosed |
| EP-0207605-A1 | Hypoglycemic thiazolidinediones | PFIZER INC. (US) | 1987-01-07 | — | — | EP | disclosed |
| WO-1986007056-A1 | HYPOGLYCEMIC THIAZOLIDINEDIONES | PFIZER INC. (US) | 1986-12-04 | — | — | WO | disclosed |